Literature DB >> 28523095

Therapeutic Advantage of the Positive Allosteric Modulators of the GABA-B Receptor.

Ahmed F Abdel-Magid1.   

Abstract

Year:  2017        PMID： 28523095      PMCID： PMC5430403          DOI： 10.1021/acsmedchemlett.7b00149

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

1.  GABA-B receptor: possible target for Parkinson's disease therapy.

Authors:  Atsushi Nambu
Journal:  Exp Neurol       Date:  2011-10-25       Impact factor: 5.330

Review 2.  GABAB receptors: structure, functions, and clinical implications.

Authors:  Eduardo E Benarroch
Journal:  Neurology       Date:  2012-02-21       Impact factor: 9.910

Review 3.  Activation of the γ-Aminobutyric Acid Type B (GABA(B)) Receptor by Agonists and Positive Allosteric Modulators.

Authors:  Katie M Brown; Kuldeep K Roy; Gregory H Hockerman; Robert J Doerksen; David A Colby
Journal:  J Med Chem       Date:  2015-04-24       Impact factor: 7.446

Review 4.  GABAB receptors as a therapeutic strategy in substance use disorders: focus on positive allosteric modulators.

Authors:  Małgorzata Filip; Małgorzata Frankowska; Anna Sadakierska-Chudy; Agata Suder; Lukasz Szumiec; Paweł Mierzejewski; Przemyslaw Bienkowski; Edmund Przegaliński; John F Cryan
Journal:  Neuropharmacology       Date:  2014-06-24       Impact factor: 5.250
  4 in total
  1 in total

1.  Allosteric Impact of the Variable Insert Loop in Vaccinia H1-Related (VHR) Phosphatase.

Authors:  Victor A Beaumont; Krystle Reiss; Zexing Qu; Brandon Allen; Victor S Batista; J Patrick Loria
Journal:  Biochemistry       Date:  2020-05-06       Impact factor: 3.162
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.